Former United States Secretary of Commerce Barbara Franklin Joins Pathway Genomics’ Board of Directors

Barbara Frankin

Former United States Secretary of Commerce Barbara Franklin Joins Pathway Genomics’ Board of Directors

 

San Diego, CA – June 16, 2015Pathway Genomics Corporation, a global precision medicine company with mobile health solutions for clinical laboratory testing to empower physicians and their patients to take control of their health and wellness, announced today that the 29th U.S. Secretary of Commerce, The Honorable Barbara Franklin is joining the company’s Board of Directors.

Click to Tweet

Mrs. Franklin served as Presidential Cabinet Secretary to the U.S. Department of Commerce and served in a variety of high-level positions for five U.S. Presidents. She is a recipient of the Woodrow Wilson Award for Public Service and now serves as President and CEO of Barbara Franklin Enterprises.

“In addition to her distinguished career in public service, Barbara Franklin has equally impressive credentials in the private sector,” said Jim Plante, Pathway’s Founder and CEO. “Having served on the Board of Directors of 14 public companies and recently inducted into the National Association of Corporate Directors Hall of Fame for her expertise and influence in corporate boardroom practices and performance, Barbara provides our company with invaluable expertise and contacts as we expand our global presence.”

“Pathway Genomics exemplifies the enterprise, innovation, and leadership that makes this country the global leader in advanced technology,” said Secretary Franklin. “I’m eager to work with Pathway Genomics, an information age company that is helping people around the world use genetic information to lead healthier lives, while also making a significant contribution to the expansion of this new and fast growing sector within the U.S. economy.”

On November 16, 2015, Mrs. Franklin will be inducted into the Financial Executives International (FEI) Hall of Fame for her exemplary leadership and integrity throughout her career.

About Pathway Genomics Corporation

Since its founding in 2008, Pathway Genomics has rapidly become a leader in the commercial healthcare industry. Pathway Genomics’ success lies in its commitment to deliver innovative healthcare solutions. The company’s program with IBM Watson is the first of its kind. The program is a smartphone app that merges artificial intelligence and deep learning with personal genetic information. The app provides users with personalized health and wellness information based on the individual’s health history.

Based in San Diego, the company’s CLIA and CAP accredited clinical laboratory provides physicians and their patients in more than 40 different countries with actionable and accurate precision healthcare information to improve or maintain, health and wellness. Pathway Genomics’ testing services cover a variety of conditions including cancer risk, cardiac health, inherited diseases, nutrition and exercise response, as well as drug response for specific medications including those used in pain management and mental health. For more about Pathway Genomics, visit www.pathway.com or follow us on Twitter, LinkedIn and Facebook.

MEDIA CONTACT

Jeff Owen

pr@pathway.com

858-633-6720

INVESTOR CONTACT

Klene Oen

investor@pathway.com